<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01942343</url>
  </required_header>
  <id_info>
    <org_study_id>5505</org_study_id>
    <nct_id>NCT01942343</nct_id>
  </id_info>
  <brief_title>Akathisia in Post Operative Outpatients Surgery</brief_title>
  <official_title>Etude de l'Effet du dropéridol et de l'Ondansetron Sur l'Incidence de l'Akathisie Post opératoire en Chirurgie Ambulatoire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to evaluate the incidence of akathisia with Droperidol,
      the prophylactic treatment of post operative nausea and vomiting, used at two different
      doses, versus control group (Ondansetron), in outpatient surgery.The primary endpoint is to
      compare the number of observed akathisia (Barnes score &gt; 1) in the Droperidol arms (0,625 mg
      and 1,25 mg) versus Ondansetron 4 hours after recovery from anesthesia.The assumption is that
      there is a greater risk of akathisia among patients taking Droperidol in prevention of NPVO,
      that among patients taking Ondansetron.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of akathisia</measure>
    <time_frame>1 day</time_frame>
    <description>The main objective of this study was to evaluate the incidence of akathisia with the waning of prophylactic treatment of PONV with droperidol used two different doses versus control group (ondansetron), ambulatory surgery</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Akathisia</condition>
  <arm_group>
    <arm_group_label>Arm 1 : Droperidol 1,25 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 : Droperidol 0,625 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3 : Odansetron 4 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration</intervention_name>
    <arm_group_label>Arm 1 : Droperidol 1,25 mg</arm_group_label>
    <arm_group_label>Arm 2 : Droperidol 0,625 mg</arm_group_label>
    <arm_group_label>Arm 3 : Odansetron 4 mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient over 18 and under 65 year-old

          -  Having a moderate to severe POVN (post operative vomiting and nausea) risk, meaning
             with at least two risk factors in the simplified Apfel score

          -  Outpatient surgery associated to a general anesthesia

          -  Patient having signed an informed consent- Patient having a social protection

        Exclusion Criteria:

          -  Contraindication to Droperidol

          -  Contraindication to Ondansetron

          -  Patients usually treated with benzodiazepine or having been treated with
             benzodiazepine within 2 days prior to anesthesia

          -  Psychiatric and Neurodegenerative diseases

          -  Severe Anxiety

          -  Contraindication to general anesthesia or one of its components

          -  Allergy to propofol

          -  Inability to get informed (patient in an emergency situation, difficulties to
             understand)

          -  Patient under judicial protection

          -  Patient under tutorship or curatorship

          -  Pregnancy reported by the patient- Breastfeeding

          -  Patient in an exclusion period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2013</study_first_submitted>
  <study_first_submitted_qc>September 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2013</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Droperidol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

